Endoscopic transgastric vs surgical necrosectomy for infected necrotizing pancreatitis: A randomized trial
J A M A: The Journal of the American Medical Association , Volume 307 - Issue 10 p. 1053- 1061
Context: Most patients with infected necrotizing pancreatitis require necrosectomy. Surgical necrosectomy induces a proinflammatory response and is associated with a high complication rate. Endoscopic transgastric necrosectomy, a form of natural orifice transluminal endoscopic surgery, may reduce the proinflammatory response and reduce complications. Objective: To compare the proinflammatory response and clinical outcome of endoscopic transgastric and surgical necrosectomy. Design, Setting, and Patients: Randomized controlled assessor-blinded clinical trial in 3 academic hospitals and 1 regional teaching hospital in the Netherlands between August 20, 2008, and March 3, 2010. Patients had signs of infected necrotizing pancreatitis and an indication for intervention. Interventions: Random allocation to endoscopic transgastric or surgical necrosectomy. Endoscopic necrosectomy consisted of transgastric puncture, balloon dilatation, retroperitoneal drainage, and necrosectomy. Surgical necrosectomy consisted of video-assisted retroperitoneal debridement or, if not feasible, laparotomy. Main Outcome Measures: The primary end point was the postprocedural proinflammatory response as measured by serum interleukin 6 (IL-6) levels. Secondary clinical end points included a predefined composite end point of major complications (new-onset multiple organ failure, intra-abdominal bleeding, enterocutaneous fistula, or pancreatic fistula) or death. Results: We randomized 22 patients, 2 of whom did not undergo necrosectomy following percutaneous catheter drainage and could not be analyzed for the primary end point. Endoscopic transgastric necrosectomy reduced the postprocedural IL-6 levels compared with surgical necrosectomy (P=.004). The composite clinical end point occurred less often after endoscopic necrosectomy (20% vs 80%; risk difference [RD], 0.60; 95% CI, 0.16-0.80; P=.03). Endoscopic necrosectomy did not cause new-onset multiple organ failure (0% vs 50%, RD, 0.50; 95% CI, 0.12-0.76; P=.03) and reduced the number of pancreatic fistulas (10% vs 70%; RD, 0.60; 95% CI, 0.17-0.81; P=.02). Conclusion: In patients with infected necrotizing pancreatitis, endoscopic necrosectomy reduced the proinflammatory response as well as the composite clinical end point compared with surgical necrosectomy. Trial Registration isrctn.org Identifier: ISRCTN07091918.
|J A M A: The Journal of the American Medical Association|
|Organisation||Department of Surgery|
Bakker, O.J, van Santvoort, H.C, van Brunschot, S, Geskus, R.B, Besselink, M.G, Bollen, T.L, … Timmer, R. (2012). Endoscopic transgastric vs surgical necrosectomy for infected necrotizing pancreatitis: A randomized trial. J A M A: The Journal of the American Medical Association, 307(10), 1053–1061. doi:10.1001/jama.2012.276